Literature DB >> 26711929

Hsa-miR-1246 and hsa-miR-1290 are associated with stemness and invasiveness of non-small cell lung cancer.

Gwangil Kim1, Hee-Jung An1, Mi-Jung Lee2, Ji-Ye Song2, Ju-Yeon Jeong2, Ji-Hyun Lee3, Hye-Cheol Jeong4.   

Abstract

OBJECTIVES: Cancer stem cells (CSCs) are considered to play a pivotal role in the process of invasion, metastasis and chemotherapy resistance. Diverse aberrantly expressed microRNAs (miRNAs) have been reported in lung cancer cells. However, there have been few reports about miRNAs that were associated with stemness and invasion of lung cancer. We investigated the role of miRNAs associated with characteristics of CSCs in non-small cell lung cancer (NSCLC).
MATERIALS AND METHODS: We cultured A549 cells (lung adenocarcinoma) and HCC1588 cells (lung squamous cell carcinoma) in serum free media condition. We isolated sphere-forming NSCLC cells and examined the microRNA expression by microarray and qRT-PCT. By inhibition of CSC-associated microRNAs, we identified the changes of stemness and invasiveness in NSCLC. RESULTS AND
CONCLUSION: We discovered 44 over-expressed, 42 down-regulated miRNAs in the sphere-forming cells compared with the parent cells of NSCLC. By in-silico database search, we selected miR-1246 and miR-1290 that were suspected to be associated with CSCs among aberrantly expressed miRNAs. Inhibition of miR-1246 and miR-1290 showed decreased stemness markers and epithelial-mesenchymal transition (EMT) markers in NSCLC. Anti-miR-1246 and anti-miR-1290 suppressed proliferation, sphere-formation, colony formation and invasion of NSCLC. CSCs-associated miR-1246, or miR-1290 may be important in the invasion or metastasis of NSCLC.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cancer stem cell; MicroRNA; Non-small cell lung cancer

Mesh:

Substances:

Year:  2015        PMID: 26711929     DOI: 10.1016/j.lungcan.2015.11.013

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  48 in total

1.  microRNA-1246 Is an Exosomal Biomarker for Aggressive Prostate Cancer.

Authors:  Divya Bhagirath; Thao Ly Yang; Nathan Bucay; Kirandeep Sekhon; Shahana Majid; Varahram Shahryari; Rajvir Dahiya; Yuichiro Tanaka; Sharanjot Saini
Journal:  Cancer Res       Date:  2018-02-01       Impact factor: 12.701

2.  The Exosome Total Isolation Chip.

Authors:  Fei Liu; Ophir Vermesh; Vigneshwaran Mani; Tianjia J Ge; Steven J Madsen; Andrew Sabour; En-Chi Hsu; Gayatri Gowrishankar; Masamitsu Kanada; Jesse V Jokerst; Raymond G Sierra; Edwin Chang; Kenneth Lau; Kaushik Sridhar; Abel Bermudez; Sharon J Pitteri; Tanya Stoyanova; Robert Sinclair; Viswam S Nair; Sanjiv S Gambhir; Utkan Demirci
Journal:  ACS Nano       Date:  2017-11-01       Impact factor: 15.881

3.  Extracellular vesicles impose quiescence on residual hematopoietic stem cells in the leukemic niche.

Authors:  Sherif Abdelhamed; John T Butler; Ben Doron; Amber Halse; Eneida Nemecek; Phillip A Wilmarth; Daniel L Marks; Bill H Chang; Terzah Horton; Peter Kurre
Journal:  EMBO Rep       Date:  2019-06-17       Impact factor: 8.807

4.  miR-20b promotes cellular proliferation and migration by directly regulating phosphatase and tensin homolog in prostate cancer.

Authors:  Ju Guo; Zewen Xiao; Xingwei Yu; Runfu Cao
Journal:  Oncol Lett       Date:  2017-09-25       Impact factor: 2.967

5.  Ascites-Derived Extracellular microRNAs as Potential Biomarkers for Ovarian Cancer.

Authors:  Luděk Záveský; Eva Jandáková; Vít Weinberger; Luboš Minář; Veronika Hanzíková; Daniela Dušková; Lenka Záveská Drábková; Iveta Svobodová; Aleš Hořínek
Journal:  Reprod Sci       Date:  2018-05-20       Impact factor: 3.060

6.  The origin of exosomal miR-1246 in human cancer cells.

Authors:  Yi-Fan Xu; Bethany N Hannafon; Ujjwol Khatri; Amy Gin; Wei-Qun Ding
Journal:  RNA Biol       Date:  2019-03-23       Impact factor: 4.652

7.  Liquid Biopsy for Colorectal Adenoma: Is the Exosomal miRNA Derived From Organoid a Potential Diagnostic Biomarker?

Authors:  Tomoyuki Handa; Masatake Kuroha; Hiroshi Nagai; Yusuke Shimoyama; Takeo Naito; Rintaro Moroi; Yoshitake Kanazawa; Hisashi Shiga; Yoichi Kakuta; Yoshitaka Kinouchi; Atsushi Masamune
Journal:  Clin Transl Gastroenterol       Date:  2021-05-12       Impact factor: 4.396

8.  Mycosis fungoides-derived exosomes promote cell motility and are enriched with microRNA-155 and microRNA-1246, and their plasma-cell-free expression may serve as a potential biomarker for disease burden.

Authors:  L Moyal; C Arkin; B Gorovitz-Haris; C Querfeld; S Rosen; J Knaneh; I Amitay-Laish; H Prag-Naveh; J Jacob-Hirsch; E Hodak
Journal:  Br J Dermatol       Date:  2021-08-13       Impact factor: 11.113

9.  Exosomes derived from embryonal and alveolar rhabdomyosarcoma carry differential miRNA cargo and promote invasion of recipient fibroblasts.

Authors:  Sandra E Ghayad; Ghina Rammal; Farah Ghamloush; Hussein Basma; Rihab Nasr; Mona Diab-Assaf; Claude Chelala; Raya Saab
Journal:  Sci Rep       Date:  2016-11-17       Impact factor: 4.379

10.  ARHGEF3 Associated with Invasion, Metastasis, and Proliferation in Human Osteosarcoma.

Authors:  Jie Gong; Wei Tang; Bin Lv; Shushu Zhang; Tingjuan Fan; Guangyu Gao; Dong Chen; Yulong Liu
Journal:  Biomed Res Int       Date:  2021-07-24       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.